?> Selling an Ophthalmology Practice: How to Evaluate a Private Equity Offer – insider.thinkgovtjobs.com

Selling an Ophthalmology Practice: How to Evaluate a Private Equity Offer

The highest headline price is not necessarily the strongest offer for an ophthalmology practice. A proposal can combine cash, rollover equity, employment compensation, and an earnout while leaving the seller with years of obligations. Comparing offers requires separating those pieces before discussing the multiple.

For physician owners in the United States, the central issue is what the transaction changes: income, control, clinical decisions, staffing, and the ability to leave.

Reconcile earnings before negotiating a multiple

Ask for a bridge from the practice’s financial statements to the buyer’s adjusted EBITDA. Review physician compensation assumptions, temporary staffing costs, related-party rent, and expenses described as nonrecurring. An adjustment is more credible when supporting records show why the cost will not continue.

Consider an illustrative offer at eight times adjusted EBITDA. A $250,000 disagreement over recurring expenses changes the implied enterprise value by $2 million. Those are hypothetical figures, not market benchmarks, but they show why the earnings definition matters as much as the multiple.

Separate the practice from the surgery center

If the physicians also own an ambulatory surgery center, determine exactly which interests are included. Review the center’s ownership documents, debt, distributions, payer agreements, and upcoming capital needs separately. Do not count the same economic benefit in both the practice valuation and the ASC valuation.

A buyer’s forecast may assume additional procedures move into the center. Test that assumption against patient needs, capacity, staffing, coverage, and applicable rules. A theoretical facility margin is not a substitute for an operational plan.

Read the governance documents with the economics

Management services organization arrangements require state-specific legal review. The label “MSO” does not settle questions about ownership, clinical control, fee arrangements, or professional responsibilities. Ask counsel to trace who can hire clinicians, set budgets, approve equipment, and resolve disputes.

Competition review also belongs in diligence. The FTC’s healthcare competition resources describe its work in provider and other healthcare markets. A smaller individual deal should not be assumed to raise no competition concerns.

Price the obligations after closing

Review the physician employment agreement alongside the purchase agreement. Model compensation under realistic schedules and payer collections. Examine call coverage, leave, productivity targets, termination rights, and any restrictions that counsel determines are applicable and enforceable.

Rollover equity needs its own review. Request the distribution waterfall, dilution provisions, transfer restrictions, and treatment if employment ends. An estimated future exit value is uncertain and should not be presented as cash available at closing.

Ask for an integration plan before signing

  • Who pays for a billing-system conversion and temporary disruption?
  • Which local managers remain accountable to physicians?
  • What patient-access and quality measures will be tracked?
  • How are staffing disputes and clinical concerns escalated?

Put competing offers into one schedule showing guaranteed proceeds, contingent proceeds, ongoing compensation, and retained risk. Have transaction counsel and tax advisers review the complete package. That comparison is more useful than choosing the largest number on the first page.

Related reading